Walgreens is considering selling itself to private equity firm Sycamore Partners after years of financial struggles and a declining stock price. The sale could be worth $9.2 to $10 billion. Experts believe that selling to a private equity buyer could help the company make operational improvements and focus on high-growth segments. Sycamore Partners, despite lacking healthcare experience, specializes in retail and consumer investments. Some experts believe that selling to a private equity firm is the right move for Walgreens in order to avoid further decline and make necessary strategic changes. However, not all analysts are convinced that the deal will go through, and other potential buyers could emerge.
Source link
Why Walgreens Is Reportedly Considering a Private Equity Buyer
